Wugen Announces Exclusive License Agreement for their Memory Natural Killer (NK) Cell-based Therapy Program with Washington University in St. Louis
ST. LOUIS, Feb. 22, 2021 /PRNewswire/ -- Wugen Inc., a biotechnology company developing novel, universal allogeneic cellular therapies, today announced that it has entered into an…
